This filing details the ownership of BioLineRx Ltd. (BLRX) by Mali Zeevi, the Chief Financial Officer. The report includes information on stock options granted under the 2003 Amended and Restated Share Incentive Plan, with various grant and vesting dates. Specifically, it lists 8 separate option grants with exercise da...

This filing details the equity holdings of Annemarie Hanekamp, Chief Commercial Officer of BioNTech SE. It includes information on stock options and performance share units granted to her, with specific exercise dates, expiration dates, and underlying security details. The filing also contains a Limited Power of Attorn...

This filing relates to a Limited Power of Attorney granted by Dr. Ulrich Wandschneider, a director of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. The attorneys-in-fact are authorized to submit necessary forms and applications to the U.S. Securities and Exchange Commission (SEC) on behalf of ...

This filing details a Limited Power of Attorney granted by Dr. Ozlem Tureci, Chief Medical Officer of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. This grants them the authority to act on her behalf for all SEC reporting obligations, including filing forms such as Form ID, passphrase updates,...

This filing details a Limited Power of Attorney granted by Helmut Jeggle, a director of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. This power of attorney authorizes the appointed individuals to act on Jeggle's behalf for all SEC reporting obligations, including submitting applications for E...

This filing details the power of attorney granted by Sierk Poetting, Chief Operating Officer of BioNTech SE, to specific individuals for handling SEC reporting obligations. It outlines the authority granted to these attorneys-in-fact to submit applications for SEC access, take necessary actions for the undersigned, exe...

This filing details a Limited Power of Attorney granted by Michael Motschmann, a director of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. The attorneys-in-fact are authorized to act on behalf of Mr. Motschmann for all SEC reporting obligations, including submitting applications for EDGAR acce...

This filing pertains to a Power of Attorney granted by Simon Turton to various individuals, including Stephen Stamp (CEO of Biodexa Pharmaceuticals Plc), Fiona Sharp (CFO), and legal representatives from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. The attorneys-in-fact are authorized to prepare and execute SEC ...

This filing details a Power of Attorney granted by Fiona Mary Powell, Chief Financial Officer of Biodexa Pharmaceuticals Plc, to Stephen Stamp and others. The attorneys-in-fact are authorized to prepare and execute necessary documents for electronic filings with the SEC, manage the EDGAR system account, obtain informat...